1. Alternatives to hysterectomy: The burden of fibroids and the quality of life
- Author
-
Rebecca Flyckt, Tommaso Falcone, and Chelsea Fortin
- Subjects
Infertility ,medicine.medical_specialty ,Uterine fibroids ,medicine.medical_treatment ,Human sexuality ,Hysterectomy ,Benign tumor ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Cost of Illness ,Surveys and Questionnaires ,Uterine Myomectomy ,medicine ,Humans ,030212 general & internal medicine ,030219 obstetrics & reproductive medicine ,Leiomyoma ,business.industry ,Obstetrics ,Pelvic pain ,Gold standard ,Obstetrics and Gynecology ,General Medicine ,Uterine Artery Embolization ,medicine.disease ,female genital diseases and pregnancy complications ,Uterine Neoplasms ,Quality of Life ,Female ,medicine.symptom ,business ,Organ Sparing Treatments - Abstract
Uterine fibroids are the most common benign tumor in reproductive-aged women. While the majority of women are asymptomatic, those with symptoms may suffer from abnormal uterine bleeding, infertility, pelvic pain or pressure, and urinary dysfunction. Fibroids represent a significant healthcare burden for women and society as a whole. Women with fibroids have compromised overall quality of life and impairment in many specific domains including work productivity, sexuality, self-image, relationships, and social emotional and physical well-being. Many women are reluctant to ask for help and delay seeking treatment. To date, myomectomy remains the gold standard for treating fibroid-related symptoms in reproductive-aged women. However, many less invasive uterine preserving approaches have been developed. Quality of life is improved in many women following treatment for fibroids. This article aims to provide an overview of the substantial impact of fibroids on health-related quality of life.
- Published
- 2017